港股午評:恆指跌1.14%止步3連漲 內房股與物管股大幅回調
格隆匯11月16日丨港股上午盤衝高回落,三大指數止步連續大漲行情。恆指跌1.14%,國指跌1.54%,恆生科技指數跌1.82%失守3800點,三者均止步3連漲。盤面上,連續大漲的科技股集體回調使大市承壓,京東、小米跌超3%,美團、百度、騰訊皆有跌幅;近日受益政策利好上漲的內房股、物管股大跌,碧桂園、雅居樂集團等多股跌超10%;汽車股、蘋果概念股、家電股、餐飲股、半導體股、內房股紛紛下跌。另一方面,國慶後全國電影單週票房止跌回升,影視娛樂股逆勢領漲,行業利好紛至沓來,中醫藥股、醫療保健設備股走強明顯,電力股、煤炭股等能源股走俏。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.